Xiidra is a prescription eye drop used to treat the signs and symptoms of dry eye disease. It is the first and only FDA-approved prescription eye drop that contains a combination of two active ingredients, lifitegrast and sodium hyaluronate. Xiidra works by reducing inflammation in the eyes, which can help reduce the signs and symptoms of dry eye disease. It is available in both single-use and multi-dose vials. Xiidra is a relatively new entrant to the optical disorders drugs market, but it has quickly become a popular treatment option for dry eye disease. It is generally well-tolerated and has been shown to be effective in reducing the signs and symptoms of dry eye disease. Companies in the Xiidra market include Shire, Novartis, Allergan, and Bausch + Lomb. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
